<?xml version="1.0" encoding="UTF-8"?>
<p id="par0135">The change in the number of cases, clinical trials, and publications for HIV is shown in 
 <xref rid="fig0035" ref-type="fig">Fig. 7</xref> , with marked time points delineating when novel anti-HIV drugs were approved by the FDA. It is generally agreed that HIV can now be managed thanks to the powerful pharmacotherapies developed since the pandemic began during the early 1980s. This success is predicated on the significant and constant increase in federal funding for HIV over the course of the epidemic, rising from just a few hundred thousand dollars in financial year (FY) 1982 to more than US$34.8 billion in FY 2019 
 <xref rid="bib0140" ref-type="bibr">[28]</xref>. This support has allowed the research community to continue to study the disease, accounting for an average of &gt;6000 papers published per year over the past 5 years, as annotated in PubMed.
</p>
